Live Breaking News & Updates on Oncology Translational Research|Page 1

Stay updated with breaking news from Oncology translational research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adlai Nortye Announces Formation of its New Scientific Advisory Board


Adlai Nortye Announces Formation of its New Scientific Advisory Board
World-leading Experts to Provide Guidance to Advance the Company s Drug Development
News provided by
Share this article
Share this article
HANGZHOU, China, March 7, 2021 /PRNewswire/ Adlai Nortye, a global clinical-stage biopharmaceutical company, today announced the formation of its new Scientific Advisory Board (SAB) comprised of five internationally renowned experts. The SAB includes Ronald M. Evans, PhD (Member of the US National Academy of Sciences, Professor at the Salk Institute and Director of the Salk s Gene Expression Laboratory), Tony Hunter, PhD (Member of the US National Academy of Sciences, Professor of Molecular and Cell Biology at the Salk Institute), Jason Pontin (Investor and former senior partner at Flagship Pioneering), Andrew Zhu, MD, PhD (Professor of Medicine at Harvard Medical School) and Wenle Xia, MD (former faculty member at Duke University). ....

New York , United States , Yangtze River , China General , New Jersey , Jia Hui , Ronaldm Evans , Andrew Zhu , Renato Dulbecco , Tony Hunter , Wenle Xia , Carsten Lu , Prnewswire Adlai Nortye , Adlai Nortye , Jason Pontin , Jiahui International Cancer Center , Professor Of Medicine At Harvard Medical School , Salk Gene Expression Laboratory , Oncology Translational Research , Translational Research Laboratory At Duke Cancer Institute , New York Times , Salk Institute For Biological , Salk Institute , Clinical Research , Yangtze River Pharmaceutical Group Co Ltd , Department Of Medicine ,